• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease.

作者信息

Contin M, Riva R, Martinelli P, Baruzzi A

机构信息

Laboratory of Neuropharmacology, University of Bologna, Italy.

出版信息

Mov Disord. 1992;7(3):244-8. doi: 10.1002/mds.870070310.

DOI:10.1002/mds.870070310
PMID:1620142
Abstract

The potential difference in the concentration-effect relationship of oral sequential doses of levodopa was explored in six Parkinsonian patients with complex fluctuating response. These patients showed "wearing-off phenomena" characterized by a transient worsening of motor function at the end of the first morning dose response to below baseline values and complained of a progressive reduction of levodopa effect during the day. A first standard levodopa dose was given in the morning, after an overnight fast and levodopa withdrawal. A second equal levodopa dose was administered immediately at the end of the first dose deterioration phase. Postimprovement worsening of motor response was also observed after the second levodopa dose in all patients. No significant difference in the pharmacokinetics of levodopa or in duration or magnitude of motor response could be appreciated between the two doses. These results further support the suggestion that, under controlled dietary conditions, plasma levodopa levels and effects relationship is reproducible between doses. Moreover, even when transient deterioration of motor function occurs between levodopa doses, the central dopaminergic system appears to remain responsive to the drug.

摘要

相似文献

1
Kinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease.
Mov Disord. 1992;7(3):244-8. doi: 10.1002/mds.870070310.
2
Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.左旋多巴/卡比多巴液剂和片剂的血浆左旋多巴及运动反应波动情况
Mov Disord. 1994 Jul;9(4):463-5. doi: 10.1002/mds.870090416.
3
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.盐酸多奈哌齐与左旋多巴/卡比多巴联合用于帕金森病患者:多次口服给药后药代动力学变化及安全性评估
Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.
4
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].[缓释左旋多巴/苄丝肼治疗帕金森病剂末运动不能的疗效]
Nervenarzt. 1995 Dec;66(12):933-41.
5
Pharmacokinetic comparison of Sinemet and Atamet (generic carbidopa/levodopa): a single-dose study.息宁与阿他美(通用名卡比多巴/左旋多巴)的药代动力学比较:一项单剂量研究。
Mov Disord. 1996 Jul;11(4):427-30. doi: 10.1002/mds.870110412.
6
Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease.左旋多巴-苄丝肼分散片与标准剂型治疗帕金森病复杂运动反应波动的浓度-效应关系
Clin Neuropharmacol. 1999 Nov-Dec;22(6):351-5.
7
[Slow-release L-dopa vs. standard L-dopa in Parkinson patients in various stages of the disease. Studies of pharmacokinetics and motor effectiveness].[缓释左旋多巴与标准左旋多巴治疗帕金森病各阶段患者的疗效比较。药代动力学及运动效能研究]
Nervenarzt. 1994 Apr;65(4):250-7.
8
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.一项关于培高利特作为帕金森病左旋多巴/卡比多巴辅助用药的多中心双盲安慰剂对照试验。
Mov Disord. 1994 Jan;9(1):40-7. doi: 10.1002/mds.870090107.
9
Treatment of early Parkinson's disease with controlled-release levodopa preparations.用控释左旋多巴制剂治疗早期帕金森病。
Neurology. 1989 Nov;39(11 Suppl 2):78-81; discussion 95.
10
Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.帕金森病中与左旋多巴输注相关的情绪和焦虑波动:初步研究结果。
Mov Disord. 1995 May;10(3):329-32. doi: 10.1002/mds.870100316.

引用本文的文献

1
Neurochemical Systems of the Retina Involved in the Control of Movement.参与运动控制的视网膜神经化学系统。
Front Neurol. 2017 Jul 5;8:324. doi: 10.3389/fneur.2017.00324. eCollection 2017.
2
Dissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making.血清素和多巴胺对道德决策中伤害评估的可分离效应。
Curr Biol. 2015 Jul 20;25(14):1852-9. doi: 10.1016/j.cub.2015.05.021. Epub 2015 Jul 2.
3
Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease.
IPX066 的群体药代动力学:一种卡比多巴-左旋多巴的口服延长释放胶囊制剂,和伴有晚期帕金森病患者的即刻释放卡比多巴-左旋多巴。
J Clin Pharmacol. 2013 May;53(5):523-31. doi: 10.1002/jcph.63. Epub 2013 Feb 20.
4
Effect of low concentrations of apomorphine on parkinsonism in a randomized, placebo-controlled, crossover study.低浓度阿扑吗啡对帕金森病影响的随机、安慰剂对照、交叉研究
Arch Neurol. 2008 Feb;65(2):193-8. doi: 10.1001/archneurol.2007.58.
5
Disease progression, drug action and Parkinson's disease: why time cannot be ignored.疾病进展、药物作用与帕金森病:为何时间不容忽视。
Eur J Clin Pharmacol. 2008 Feb;64(2):207-16. doi: 10.1007/s00228-007-0427-9. Epub 2007 Dec 19.
6
Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease.模拟帕金森病对外源性左旋多巴和内源性左旋多巴产生的短期和长期反应。
J Pharmacokinet Pharmacodyn. 2004 Jun;31(3):243-68. doi: 10.1023/b:jopa.0000039566.75368.59.
7
Pharmacokinetic optimisation in the treatment of Parkinson's disease.帕金森病治疗中的药代动力学优化
Clin Pharmacokinet. 1996 Jun;30(6):463-81. doi: 10.2165/00003088-199630060-00004.